Neovasc Inc. (NVCN) Fundamentals

Neovasc Inc is a specialty medical device company. It develops, manufactures and markets products for the rapidly growing cardiovascular marketplace. Its products the Neovasc Reducer (Reducer), for the treatment of refractory angina, which is not currently commercially available in the United States and has been commercially available in Europe since 2015, and the Tiara, for the transcatheter treatment of mitral valve disease, which is under clinical investigation in the United States, Canada, Israel and Europe. The company earns revenue from one source, the Reducer.
SHARE INFORMATION
Market Cap$ 18,625,941
Shares Outstanding2,707,522
Float2,730,095
Percent Float99.52%
Short Interest0.00
Short Percent Float0.0%
Short Interest Ratio0.00
Short Interest Date-
Latest Fiscal Dividend Per Share$ 0.00
Latest Fiscal Revenue$ 2,547,406
Latest Fiscal EPS$ -9.46
Latest Fiscal Date2021-12-31
DIVIDENDS
Dividend (3 Years)$ 0.00
Dividend (5 Years)$ 0.00
Ex Dividend Date-
Dividend Rate$ 0.00
Dividend Yield0.0%
Payment Cash-
HOLDERS
Institutions17
Institutional Holdings Date2022-08-31
Institutional Bought Previous 3 Months-
Institutional Holdings Percent1.7%
Institutional Sold Previous 3 Months-
Insider Holdings Date-
Insider Bought Previous 3 Months-
Insider Holdings Percent0.0
Insider Sold Previous 3 Months-
Insider Shares Owned-
TRADING INFO
52 Week High$ 20.58
52 Week Low$ 4.59
52 Week High Change$ -62.96
21 Day Moving Average$ 7.0455
21 Day Extended Moving Average$ 6.9508
50 Day Moving Average$ 7.0552
50 Day Extended Moving Average$ 6.9826
200 Day Moving Average$ 8.909
200 Day Extended Moving Average$ 9.8531
10 Day Average Volume7,051
20 Day Average Volume9,176
30 Day Average Volume10,704
50 Day Average Volume12,569
Alpha-0.090684
Beta2.2291
Standard Deviation0.322535
R20.121606
7 Day Price Change$ 0.40
7 Day Percent Change6.26%
21 Day Price Change$ -0.57
21 Day Percent Change-7.74%
30 Day Price Change$ -0.86
30 Day Percent Change-11.24%
Month to Date Price Change$ -0.57
Month to Date Percent Change-7.74%
Quarter to Date Price Change$ 0.70
Quarter to Date Percent Change11.49%
180 Day Price Change$ -3.51
180 Day Percent Change-34.09%
200 Day Price Change$ -5.11
200 Day Percent Change-42.94%
Year to Date Price Change$ -4.93
Year to Date Percent Change-42.04%

Neovasc Inc. (NVCN) Key Ratios

PROFITABILITY
EBIT Margin-1,095.4%
EBITDA Margin-1,077.5%
Pre-Tax Profit Margin-2,110.9%
Profit Margin Count0.0%
Gross Margin76.9%
Profit Margin TOT0.0%
INCOME STATEMENTS
Revenue$ 2,891,351
Revenue Per Share$ 1.054
Revenue (3 Years)$ 0.00
Revenue (5 Years)$ 0.00
FINANCIAL STRENGTH
Price to Tangible Book0.50
Total Debt To Equity0.40
Int Coverage-30.10
Current Ratio9.70
Leverage Ratio1.30
Quick Ratio9.30
Long Term Debt To Capital0.25
VALUATION MEASURES
PE Ratio-0.60
Enterprise Value$ -7,568,125
Price to Sales6.442
Price to Free Cash-0.70
PE High Last 5 Years-0.10
Price To Book0.50
Price To Cash Flow0.00
PE Low Last 5 Years-0.40
Price to Tangible Book0.50
MANAGEMENT EFFECTIVENESS
Receivables Turnover0.90
Invoice Turnover0.30
Assets Turnover0.00
Return Assets-49.38
Return on Equity-66.31
Return on Capital-53.91

Neovasc Inc. (NVCN) Profile

PROFILE INFO
Issue TypeCS
SEC TypeEQS
AuditorGRANT THORNTON LLP
CEOFredericus A. Colen
Emplyoees54
Last AuditUE
CIK0001399708
IndustryMedical Devices & Instruments
SectorHealthcare
NAICSSurgical and Medical Instrument Manufacturing(339112)
CONTACT INFO
Address13562 Maycrest Way
Suite 5138
Richmond, BC V6V 2J7
Websitehttps://www.neovasc.com
Facsimile+1 604 270-4384
Telephone+1 604 270-4344
Emailinvestors@neovasc.com


Your Recent History
NASDAQ
NVCN
Neovasc
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

Log in to InvestorsHub
Register Now

NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.